Diadem Biotherapeutics has a total of 10 patents globally, out of which 2 have been granted. Of these 10 patents, more than 90% patents are active. The United States of America is where Diadem Biotherapeutics has filed the maximum number of patents. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Diadem Biotherapeutics.
Diadem Biotherapeutics was founded in the year 2019. Diadem Biotherapeutics is a biotechnology company dedicated to developing organically produced bio-therapeutical materials. Diadem creates exosomes to address autoimmune and chronic inflammatory diseases.
Do read about some of the most popular patents of Diadem Biotherapeutics which have been covered by us in this article and also you can find Diadem Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Diadem Biotherapeutics patent portfolio.
How many patents does Diadem Biotherapeutics have?
Diadem Biotherapeutics has a total of 10 patents globally. These patents belong to 1 unique patent families. Out of 10 patents, 9 patents are active.
How Many Patents did Diadem Biotherapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Diadem Biotherapeutics Applications Filed | Diadem Biotherapeutics Patents Granted |
| 2023 | – | 2 |
| 2022 | 1 | – |
| 2021 | 9 | – |
How many Diadem Biotherapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Diadem Biotherapeutics File in Different Countries?
Countries in which Diadem Biotherapeutics Filed Patents
| Country | Patents |
| United States Of America | 4 |
| Australia | 1 |
| Korea (South) | 1 |
| Canada | 1 |
| Europe (EPO) | 1 |
| Japan | 1 |
Where are Research Centers of Diadem Biotherapeutics Patents Located?
The Research Centre for all the Diadem Biotherapeutics patents is the United States of America.
Best Diadem Biotherapeutics Patents
WO2021159016A1 is the most popular patent in the Diadem Biotherapeutics portfolio. It has received 3 citations so far from companies like Reneuron Limited.
What Percentage of Diadem Biotherapeutics US Patent Applications were Granted?
Diadem Biotherapeutics (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Diadem Biotherapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Diadem Biotherapeutics?
| Law Firm | Total Applications | Success Rate |
| Nixon Peabody Llp | 3 | 0% |
List of Diadem Biotherapeutics Patents
| Diadem Biotherapeutics Patents | Title |
| US11746138B2 | Artificial Synapses |
| US11578116B2 | Extracellular Vesicles Comprising Engineered Fusion Proteins |
| US20230312678A1 | Artificial Synapses |
| US20220411481A1 | Artificial Synapses |
| EP4099984A1 | Artificial Synapses |
| CA3169228A1 | Artificial Synapses |
| AU2021215935A1 | Artificial Synapses |
| JP2023512562A | Artificial Synapse |
| KR1020220139926A | Artificial Synapse |
| WO2021159016A1 | Artificial Synapses |
What are Diadem Biotherapeutics’ key innovation segments?
What Technologies are Covered by Diadem Biotherapeutics?
The chart below distributes patents filed by Diadem Biotherapeutics